Oncolix, Inc.
company.status.inactiveCIK 1584137fmd_036Q0YY5G3359PV97KVQDCAGWRManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2013 to Sep 30, 2018, 20 periods
Latest annual · FY2014
Millions- Total revenues
- 0
- Operating income
- (0)
- Net income
- (3)
Latest quarter · Q3 FY2018
Millions- Net income
- (1)
Oncolix, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2017 | FY2016 | Change | Source |
|---|---|---|---|---|
| Net income | -$3.4 million | -$1.4 million | 10-K 2018-03-14 · proof | |
| Cash from operating activities | -$2.4 million | -$445,269 | 10-K 2018-03-14 · proof | |
| Total assets | $889,397 | $420,842 | +111.3% | 10-K 2018-03-14 · proof |
| Total liabilities | $2.5 million | $2.5 million | -0.6% | 10-K 2018-03-14 · proof |
| Cash and cash equivalents | $494,410 | $15,264 | +3,139.1% | 10-K 2018-03-14 · proof |
- What was Oncolix, Inc.'s net income in fiscal 2017?
- Oncolix, Inc. reported net income of -$3.4 million for fiscal 2017 (the year ended Dec 31, 2017), against -$1.4 million the year before. Source: the 10-K filed with the SEC on Mar 14, 2018. SEC
- What was Oncolix, Inc.'s cash from operating activities in fiscal 2017?
- Oncolix, Inc. reported cash from operating activities of -$2.4 million for fiscal 2017 (the year ended Dec 31, 2017), against -$445,269 the year before. Source: the 10-K filed with the SEC on Mar 14, 2018. SEC
- What are Oncolix, Inc.'s total assets?
- As of Dec 31, 2017, Oncolix, Inc. reported total assets of $889,397, against $420,842 a year earlier (+111.3%). Source: the 10-K filed with the SEC on Mar 14, 2018. SEC
- What are Oncolix, Inc.'s total liabilities?
- As of Dec 31, 2017, Oncolix, Inc. reported total liabilities of $2.5 million, against $2.5 million a year earlier (-0.6%). Source: the 10-K filed with the SEC on Mar 14, 2018. SEC
- What are Oncolix, Inc.'s cash and cash equivalents?
- As of Dec 31, 2017, Oncolix, Inc. reported cash and cash equivalents of $494,410, against $15,264 a year earlier (+3,139.1%). Source: the 10-K filed with the SEC on Mar 14, 2018. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1584137&period_type=annual&limit=5"Information only, not investment advice.